share_log

LevelJump Announces That It Will Be Delayed in Filing Year-End Reporting Documents

LevelJump Announces That It Will Be Delayed in Filing Year-End Reporting Documents

LevelJump宣佈將推遲提交年終報告文件
newsfile ·  04/15 22:33

Toronto, Ontario--(Newsfile Corp. - April 15, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") announces today that it anticipates the filing of its annual financial statements, management's discussion and analysis and related officer certifications for the financial year ended December 31, 2023 (collectively, the "Annual Filings") will be delayed beyond the required filing deadline under Parts 4 and 5 of National Instrument 51-102 - Continuous Disclosure Obligations and pursuant to National Instrument 52-109 - Certification of Disclosure in Issuer's Annual and Interim Filings, being April 29, 2024 (the "Filing Deadline").

安大略省多倫多--(資訊股份有限公司 - 2024年4月15日) - LevelJump Healthcare Corp. (TSXV: JUMP)(“LevelJump”或“公司”)今天宣佈,公司預計其年度財務報表,管理討論與分析以及有關負責人證明將逾期提交,截止日期將超過 2024 年 4 月 29 日根據《51-102國家標準第4、 5部分細則-持續披露義務》,並按照《發行人年度與中期報告披露的披露證明的52-109國民儀器》(“年度備案”)規定的《52-109國民儀器》(“年度備案”)。

In light of a recent change in the Company's auditor to Kreston GTA LLP (see the Company's Notice of Change of Auditors filed on SEDAR+ dated March 19, 2024) and an exceptionally large amount of audit work related to the Company's Alberta acquisitions during the 4th quarter (see the Company's news release dated October 11, 2023), the Company has determined that it will not be able to complete the audit and file the Annual Filings by the Filing Deadline. The Company intends to work closely with its auditor and expects to file the Annual Filings as soon as possible, and in any event no later than June 28, 2024.

考慮到公司核數師最近更換爲 Kreston GTA LLP(請參見公司於 2024 年 3 月 19 日在 SEDAR+ 文件中提交的核數師更換通知),並且與 Alberta 收購有關的審核工作數量非常大(請參見其他公司新聞公告其四季度,於 2023 年 10 月 11 日發佈),公司已經確定將無法在截止日期之前完成審核和備案。公司打算與其核數師密切合作,並預計儘快提交年度備案,但無論如何不遲於 2024 年 6 月 28 日。th根據《12-203國家準則-管理停止交易命令》(“NP 12-203”),公司發佈了違約通告。公司已向安大略證券委員會,作爲公司的主要監管機構,請求根據 NP 12-203 頒發管理停止交易命令 (MCTO),以解決與年度備案有關的違約問題。頒發 MCTO 命令是安大略證券委員會的自由裁量權。頒發 MCTO 命令通常不影響未曾擔任公司董事,高管或內部人員的個人進行證券交易的能力。如果頒發 MCTO 命令,其將持續到該違約得到解決爲止。

The Company is providing this default announcement in accordance with National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"). The Company has made an application to the Ontario Securities Commission, as principal regulator of the Company, for a management cease trade order ("MCTO") under NP 12-203 in respect of the anticipated default regarding the Annual Filings. The granting of the MCTO is at the discretion of the Ontario Securities Commission. The issuance of the MCTO generally will not affect the ability of persons who have not been directors, officers or insiders of the Company to trade in their securities. In the event that the MCTO is granted, it will be in effect until the default is remedied.

公司打算按照NP 12-203中的“替代信息指引”的規定,發佈每兩週一次的新聞發佈形式的違約狀態報告,只要公司處於違約狀態。截至今日新聞發佈日,公司沒有破產程序,並且沒有其他未公開的公司事務的重要信息.

The Company intends to follow the provisions of the Alternative Information Guidelines set out in NP 12-203, including the issuance of bi-weekly default status reports in the form of news releases, for as long as the Company remains in default. The Company confirms as of the date of this news release that there is no insolvency proceeding against it and there is no other material information concerning the affairs of the Company that has not been generally disclosed.

About LevelJump Healthcare

關於LevelJump Healthcare

LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.

LevelJump Healthcare Corp.(TSXV:JUMP)通過其遠程放射科部門向客戶醫院和成像中心提供遠程醫療解決方案,以及通過其診斷中心提供當面的放射診斷服務。JUMP主要關注緊急患者的重症監護,與我們服務的社區建立了重要關係。

ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

董事會代表
LEVELJUMP HEALTHCARE CORP。

Mitchell Geisler
Chief Executive Officer

Mitchell Geisler
首席執行官

Caitlin-Robyn Densmore
Business Development Manager
Caitlin.Densmore@leveljumphealthcare.com
(437) 214-1568

Caitlin-Robyn Densmore
業務開發經理
Caitlin.Densmore@leveljumphealthcare.com
(437) 214-1568

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

關於前瞻性信息的警告聲明

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

本新聞稿包含與公司業務計劃和行業前景有關的“前瞻信息”,這些信息屬於適用證券法律的範疇。雖然公司在官員和董事的經驗、當前情況和預期未來發展以及其他被認爲適當的因素的基礎上認爲,這些前瞻信息所反映的期望是合理的,但不應該過度依賴它們,因爲公司不能保證其正確性。實際結果和發展可能與這些聲明所預示的有很大不同。本新聞稿中的聲明是截至本發佈日期發表的,公司假定不承擔更新這些聲明或修訂這些聲明以反映適用證券法律規定之外的新事件或情況的責任。公司不承擔針對公司、加拿大遠程放射服務公司、它們的證券或它們的相應財務或業務成果(如適用)所作出的第三方分析、期望或聲明的評論義務。

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

該交易所及其監管服務供應商(如交易所的政策中所定義)不承擔對本新聞稿的充分性或準確性的責任。

The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.

所提供的證券尚未根據修正後的1933年《美國證券法》(“美國證券法”)或任何美國州證券法註冊,也不會註冊,並且在未進行美國證券法和適用的美國州證券法要求的註冊或適用豁免事宜的情況下,不得在美國或向美國人或代表他們的帳戶或利益進行出售。本新聞稿不構成在美國出售或購買證券的要約,也不在任何其他司法管轄區內構成要約。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論